The review highlights combination therapies as a strategy that may help integrate CAR-T cells into glioblastoma treatment and improve outcomes.
First-pass extracted concept
combination therapies
Candidate: concept label2 source documents2 linked claims
Live refresh every 5sNext refresh in 5s
Extracted Explainers
What the tool is doing
Evidence Snippets
continued research and innovation in genetic engineering and combination therapies
Additionally, it delves into the various applications of mRNA in cancer treatment, including mRNA tumor vaccines, adoptive cell transfer therapies, restoration of tumor suppressors, immunomodulatory factors, combination therapies, and other emerging treatments.
Supporting Sources
Linked Claims
mRNA in cancer treatment is described as being applied to tumor vaccines, adoptive cell transfer, tumor suppressor restoration, immunomodulatory factors, and combination therapies.
Quoted textsource-backed
Additionally, it delves into the various applications of mRNA in cancer treatment, including mRNA tumor vaccines, adoptive cell transfer therapies, restoration of tumor suppressors, immunomodulatory factors, combination therapies, and other emerging treatments.
Further innovation in genetic engineering and combination therapies is needed to fully realize the potential of CAR-T cells in glioblastoma.
Quoted textsource-backed
emphasizing the need for continued research and innovation in genetic engineering and combination therapies to fully realize the potential of CAR-T cells